Back to TCRX

Lynx1 Capital Management LP → TCRX

Lynx1 Capital Management LP TCRX Position History

TScan Therapeutics, Inc. • Healthcare

Quarters held
5
Latest value
$2.5M
Q3 2026
Peak value
$8.1M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$8M
Q1 2026$8.1M
Q2 2026$7.9M
Q2 2026$7.9M
Q3 2026$2.5M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$2.5M8.02M——
Q2 2026$7.9M8.02M——
Q2 2026$7.9M8.02M——
Q1 2026$8.1M8.02M——
Q4 2025$8M8.02M——

Other funds holding TCRX

Other Lynx1 Capital Management LP positions

GHRS

GH RESEARCH PLC

$356.5M
GHRS

GH RESEARCH PLC

$311.4M
STOK

STOKE THERAPEUTICS INC

$171.5M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
CGEM

CULLINAN THERAPEUTICS INC

$163.2M
STOK

STOKE THERAPEUTICS INC

$155.1M
GHRS

GH RESEARCH PLC

$151.3M
CGEM

CULLINAN THERAPEUTICS INC

$137.6M